To get to over $1 billion market cap which is around $8-10, we will need a net profit of around $25-30m... Fast growing companies can have large PE's, so a PE of 30-40 seems reasonable...
Receipts from BHA are anticipated to be in excess of $0.8m and provide the Company with combined results for full FY17 of $20.3m (an increase of 399% on FY16 of $4.1m).
A big if, but if FY18 is just as good as FY17 in terms of growth, we will have revenue of around $100m... Net profit could come in at close to $20m-25m...
There are a lot of variables, and the big unknown is international expansion, but the footprints are there for great growth to come, and $1b market cap may not seem as unrealisic as now in a couple years time... I think we will have more of an idea by the end of this year what our future looks like...
- Forums
- ASX - By Stock
- BIG
- Ann: FY17 Cash Revenue Guidance Update
Ann: FY17 Cash Revenue Guidance Update, page-78
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online